The Technical Services Veterinarian will support and expand sales of veterinary products by providing technical information and assistance to veterinarians, academics, and end-users of assigned Boehringer Ingelheim product within assigned region (BC and Alberta primarily) and across Canada as needed.
Positions Boehringer Ingelheim as an important key player in the specific species sector (Pet) by providing the latest up-to-date product knowledge and information on diseases to academia and key opinion leaders nationally and internationally.
- Support sales and marketing by producing technical information materials in line with sales and marketing strategy for the Pet Business Unit, for the Sales Team, Veterinary customers and end users.
- Influence customers to achieve financial performance requirements for the business by proactively promoting Boehringer Ingelheim products in the field through field rides and direct customer contact.
- Build and maintain relationships with opinion leaders and veterinarians on a regular basis to identify disease trending and customer needs.
- Provide supporting input on customer needs to team members through agreed communication channels. Proactive contribution and prioritization during species tactics/strategy meetings to build strategic plans. Recommend technical approaches that are aligned with business and brand strategy to provide solutions.
- Respond in a timely manner to all inquiries on species-specific products and investigate and resolve complex adverse reactions and associated customer complaints.
- Support product launches, territory manager training and veterinary customer and end-user meetings as needed.
- Adheres to pharmacovigilance SOPs and processes. Perform all BI business in accordance with all regulations and BI compliance guidelines and procedures.
- Positions the company as an important key player in the specific species sector (Pet) by providing the latest up-to-date product knowledge and information on diseases to academia and key opinion leaders nationally and internationally.
- DVM or equivalent degree, with valid Canadian veterinary license required.
- Board certification in a clinical discipline or DVM plus relevant advanced post-graduate expertise in a relevant clinical discipline preferred.
- Minimum of 5 years of clinical or academic practice preferred.
- Valid drivers license.
- Ability to travel up to 50% of the time.
Boehringer Ingelheim (Canada) Ltd.
Improving the health of humans and animals is the goal of Boehringer Ingelheim, a research-driven pharmaceutical company. In doing so, the focus is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
Family-owned since it was established in 1885, Boehringer Ingelheim is one of the top 20 companies in the pharmaceutical industry. Some 50,000 employees create value through innovation daily for the three business areas of human pharmaceuticals, animal health and biopharmaceuticals. In 2018, Boehringer Ingelheim achieved net sales of around 17.5 billion euros. R&D expenditure of almost 3.2 billion euros, corresponded to 18.1 per cent of net sales.
As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment.
The Canadian headquarters of Boehringer Ingelheim was established in 1972 in Montréal, Québec and is now located in Burlington, Ontario. Boehringer Ingelheim employs approximately 600 people across Canada.
More information about Boehringer Ingelheim can be found at www.boehringer-ingelheim.ca or in our annual report: http://annualreport.boehringer-ingelheim.com.
About the Animal Health Business Unit
We passionately believe in a future in which no animal suffers from a preventable disease.
We provide advanced, preventive animal healthcare. We develop vaccines, parasiticides and pharmaceuticals that protect animals against disease and pain. And we develop new therapies to help those who care for animals to manage chronic diseases more effectively, limiting pain and slowing down disease progression.
Our people are driven by the fundamental principle of prevention over treatment.
Across the globe, we are creating the future of animal wellbeing. It is a future defined by science and powered by innovation. Why innovate? The population of companion animals and its importance for humans is steady increasing. The demand for animal protein is rising. Animal-originated diseases remain a continuous risk to human beings.
We must go beyond medicine to better predict, detect and prevent animal diseases before they arise. Why does this matter? Animal wellbeing enriches humanity. It is the basis of our connection to the animal world. From the vets dedicated to the highest patient care, to the livestock owners who depend on the health of their herds, to the families looking after much-loved pets, animal health and happiness is a vital part of a functional society.
We care for well beings, animals and humans. This is why our commitment to preventive care matters. This is what inspires us.
We are here to anticipate, prevent and ameliorate diseases, enabling those who raise and care for animals to focus on their wellbeing.
We are proud of our work through which we contribute to a better world.
We are the Animal Health Business Unit of Boehringer Ingelheim.
For complete details about this career opportunity and to apply, visit:
Enter “Canada” in the Location field to narrow your search
Create an Account as a New User to apply on-line, create job alerts, and more.